BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10583228)

  • 1. Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?
    Daniels JT; Davis BJ; Houde-McGrail L; Byrd JC
    Br J Haematol; 1999 Nov; 107(2):381-3. PubMed ID: 10583228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22).
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Byrd JC; Davey FR; Schiffer CA; Bloomfield CD
    Blood; 1997 Aug; 90(4):1643-8. PubMed ID: 9269784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
    Bacher U; Schnittger S; Kern W; Trenn G; Weisser M; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2006 Jul; 168(2):172-4. PubMed ID: 16843110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translocation (3;21;8)(q21;q22;q22) in a patient with acute myeloid leukemia. A case report and review of prognostic indicators.
    Giles FJ; Kanemaki TJ; Schreck RR; Qasabian L; Fuerst MP; Lim SW
    Cancer Genet Cytogenet; 1998 Jul; 104(1):66-9. PubMed ID: 9648562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia.
    Itoh S; Sugawara T; Enomoto S; Ono Y; Numaoka H; Utsugisawa T; Murai K; Ishida Y; Kuriya S
    Am J Hematol; 2002 Jan; 69(1):59-63. PubMed ID: 11835333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.
    Yang DH; Lee JJ; Mun YC; Shin HJ; Kim YK; Cho SH; Chung IJ; Seong CM; Kim HJ
    Am J Hematol; 2007 Jan; 82(1):1-5. PubMed ID: 16986129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD56 expression is an independent prognostic factor for relapse in acute myeloid leukemia with t(8;21).
    Iriyama N; Hatta Y; Takeuchi J; Ogawa Y; Ohtake S; Sakura T; Mitani K; Ishida F; Takahashi M; Maeda T; Izumi T; Sakamaki H; Miyawaki S; Honda S; Miyazaki Y; Taki T; Taniwaki M; Naoe T
    Leuk Res; 2013 Sep; 37(9):1021-6. PubMed ID: 23810283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor outcome in a pediatric patient with acute myeloid leukemia associated with a variant t(8;21) and trisomy 6.
    Kelly MJ; Meloni-Ehrig AM; Manley PE; Altura RA
    Cancer Genet Cytogenet; 2009 Feb; 189(1):48-52. PubMed ID: 19167612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature.
    Sugimoto Y; Nishii K; Sakakura M; Araki H; Usui E; Lorenzo V F; Hoshino N; Miyashita H; Ohishi K; Katayama N; Shiku H
    Hematol J; 2004; 5(1):84-9. PubMed ID: 14745436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT3-internal tandem duplication in a pediatric patient with t(8;21) acute myeloid leukemia.
    Kawamura M; Kaku H; Ito T; Funata N; Taki T; Shimada A; Hayashi Y
    Cancer Genet Cytogenet; 2010 Dec; 203(2):292-6. PubMed ID: 21156247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo acute myelogenous leukemia with trilineage myelodysplasia associated with t(8;21)(q22;q22).
    Fujisawa S; Togawa J; Tanaka M; Koharazawa H; Aoba M; Fujita H; Murata T; Kanamori H; Matsuzaki M; Mohri H; Ishigatsubo Y
    Intern Med; 1999 Jul; 38(7):607-11. PubMed ID: 10435370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural cell adhesion molecule (CD56)-positive acute myelogenous leukemia and myelodysplastic and myeloproliferative syndromes.
    Mann KP; DeCastro CM; Liu J; Moore JO; Bigner SH; Traweek ST
    Am J Clin Pathol; 1997 Jun; 107(6):653-60. PubMed ID: 9169661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute myeloid leukaemia with t(8;21)(q22;q22.3) and loss of the X chromosome.
    Mohamed M; Dun K
    BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26250367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukemia with new complex t(8;21;22) induced hemophagocytic lymphohistiocytosis: A case report.
    Wu Y; Xu J; Shen K; Ji J; Yang C; Liu T; Xiang B
    Medicine (Baltimore); 2018 Nov; 97(44):e12762. PubMed ID: 30383631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD56 antigen expression and hemophagocytosis of leukemic cells in acute myeloid leukemia with t(16;21)(p11;q22).
    Jekarl DW; Kim M; Lim J; Kim Y; Han K; Lee AW; Kim HJ; Min WS
    Int J Hematol; 2010 Sep; 92(2):306-13. PubMed ID: 20694842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD56 antigenic expression in acute myeloid leukemia identifies patients with poor clinical prognosis.
    Raspadori D; Damiani D; Lenoci M; Rondelli D; Testoni N; Nardi G; Sestigiani C; Mariotti C; Birtolo S; Tozzi M; Lauria F
    Leukemia; 2001 Aug; 15(8):1161-4. PubMed ID: 11480556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.
    Byrd JC; Weiss RB; Arthur DC; Lawrence D; Baer MR; Davey F; Trikha ES; Carroll AJ; Tantravahi R; Qumsiyeh M; Patil SR; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
    J Clin Oncol; 1997 Feb; 15(2):466-75. PubMed ID: 9053467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease in a patient having acute myelogenous leukemia with t(16;21)(p11;q22) treated by allogeneic bone marrow transplantation.
    Okoshi Y; Shimizu S; Kojima H; Obara N; Mukai HY; Komeno T; Hasegawa Y; Mori N; Nagasawa T
    Acta Haematol; 2001; 105(1):45-8. PubMed ID: 11340253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Significance of CD200 and CD56 Expression in Patients with Acute Myeloid Leukemia.
    Aref S; Abousamra N; El-Helaly E; Mabed M
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):743-748. PubMed ID: 32212802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.